Pieris Pharmaceuticals Income from Continuous Operations 1970-1969 | PVLA
Pieris Pharmaceuticals income from continuous operations from 1970 to 1969. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Pieris Pharmaceuticals Annual Income from Continuous Operations
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Income from Continuous Operations
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
